Kolexia
Bouchahda Mohamed Oncologie médicale
Bouchahda Mohamed
Oncologie médicale
Hôpital Paul Brousse
Villejuif, France
84 Activités
48 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs du foie Tumeurs du pancréas Seconde tumeur primitive Adénocarcinome Fatigue Urgences Carcinome pulmonaire à petites cellules

Collaborateurs

Voir plus
Levi Francis
Levi Francis
Hôpital Paul Brousse, Villejuif, France
Innominato Pasquale
Innominato Pasquale
Hôpital Paul Brousse, Villejuif, France
Adam Rene
Adam Rene
Hôpital Paul Brousse, Villejuif, France
Ducreux Michel
Ducreux Michel
Gustave-Roussy, Villejuif, France

Industries

Voir plus
MSD
6 collaboration(s)
Dernière en 2023
AstraZeneca
6 collaboration(s)
Dernière en 2022
B3TSI
2 collaboration(s)
Dernière en 2021
Lilly
2 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948).
BMJ open   07 juin 2023
MULTIDOM: Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo Domomedecine Plateform
Essai Clinique (Ramsay Générale de Santé)   20 avril 2023
Nivolumab timing as a major survival predictor in patients with stage IV non–small cell lung cancer.
2022 ASCO Annual Meeting I   02 juin 2022
Reply to P. Gazzaniga et al.
JCO precision oncology   03 mars 2022
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.
Cancers   11 février 2022
Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.
Scientific reports   14 décembre 2021
Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   08 mai 2021
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5-fluorouracil and leucovorin combination as first- or second-line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial.
International journal of cancer   03 décembre 2020
Undetectable -Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With -Mutant Metastatic Colorectal Cancer.
JCO precision oncology   16 septembre 2020
Hepatic metastases resection after cetuximab: are we missing something?
The Lancet. Oncology   13 juillet 2020